The vacatur removes the certainty of patent invalidity that Align had secured at the PTAB. Monitor the PTAB remand proceedings, if the Board finds Carrier's provisional lacks written description support, Carrier drops as prior art, strengthening Dental Monitoring's patent and potentially pressuring Align's clear aligner monitoring products. Conversely, if Carrier survives, the invalidity finding may be restored. The related § 101 ruling on claims 1, 7, and 12 provides some offsetting relief for Align.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 11 $172.96entry
- T+1 · 3mo ago +0.61%α +0.36% · $174.02
- T+5 · 3mo ago −2.92%α −2.51% · $167.91
- T+20 · 2mo ago −11.58%α −10.53% · $152.92
- T+60 · 13d ago −4.66%α −4.17% · $164.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Federal Circuit vacated the PTAB's IPR decision invalidating Dental Monitoring's patent claims, ruling that the Board applied the wrong legal standard for determining whether a prior art reference (Carrier) qualifies for an earlier effective filing date. The court held that Carrier must satisfy the written description requirement of § 112(a) to be prior art, not merely 'ministerial' requirements. The case is remanded for the Board to reassess Carrier's prior art status under the correct standard. This is a procedural loss for Align, the patent claims are not reinstated, but the invalidity finding is undone pending remand, reopening uncertainty around the '409 patent.
Court Ruling Details
Key Facts
- Federal Circuit vacated PTAB's final written decision that had found claims 1-15 of Dental Monitoring's '409 patent unpatentable as obvious.
- Court held that to qualify as prior art under AIA § 102(d)(2), a reference patent must satisfy the written description requirement of § 112(a) for at least one of its claims, not merely 'ministerial' requirements.
- Case remanded to PTAB to determine whether Carrier's provisional application provides written description support for Carrier's claims.
- In a related decision, claims 1, 7, and 12 of the '409 patent were already found directed to ineligible subject matter, limiting the scope of remand.
- Costs awarded to appellant Dental Monitoring.
Financial Impact
No damages awarded. The ruling vacates the IPR invalidity finding, restoring uncertainty around the '409 patent. Align's potential exposure is increased litigation risk and possible future licensing costs or product design-around expenses, but no dollar figure is stated in the opinion.
Risk Factors
- PTAB on remand may find Carrier's provisional lacks written description support, removing Carrier as prior art and potentially reviving the '409 patent's validity.
- Even if Carrier is reinstated as prior art, the § 101 ruling on three claims limits the scope of the patent, but remaining claims could still be asserted against Align.
- Appeal by Dental Monitoring on the § 101 ruling is possible, creating further uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-7d23a6f1a8-ALGN |
Track record
19 reports on ALGN
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $165.98 −1.39% settles Dec 14
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $165.98 −3.54% settles Dec 10
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $166.00 Now $165.98 −0.01% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $165.98 +4.15% settles Dec 4
- Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $165.98 +9.50% settles Dec 2
- Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $165.98 +7.98% settles Nov 27
- Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $165.98 +6.73% settles Nov 19
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $165.98 −11.47% ▼ −11.47% −14.93% vs SPY
- Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $165.98 +7.11% ▼ −6.20% −6.52% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers